Dr. Javid Moslehi is a cardiologist who specializes in the cardiovascular health of cancer patients, cancer survivors and patients with immunological or metabolic problems that affect cardiovascular health. He serves as chief of UCSF's cardio-oncology and immunology section. Moslehi's research focuses on how diseases of the cardiovascular system impact cancer patients and survivors. He is also interested in inflammatory heart conditions, such as myocarditis. Moslehi earned his medical degree from the University of Connecticut School of Medicine. He completed a residency in internal medicine at the Johns Hopkins Hospital. At Brigham and Women's Hospital, he completed a fellowship in cardiology and a postdoctoral research fellowship in oncology. His career includes directing cardio-oncology programs at the Dana-Farber Cancer Institute and Vanderbilt University Medical Center. He is the UCSF William Grossman Distinguished Professor in Cardiology.

Dr Holly Voges is a Team Leader in the Heart Regeneration Group at the Murdoch Children’s Research Institute. She obtained her PhD from the Faculty of Medicine at the University of Queensland in 2019 where she used pluripotent stem cell models of the heart to investigate innate regenerative potential and the role of cell-cell interactions in heart maturation. Her first postdoc was in the Drug Discovery Facility at MCRI, specialising in high throughput drug screening and automation of pluripotent stem cell-derived organoids. In 2023, she joined the Heart Regeneration Laboratory at MCRI. Her research now focuses on bioengineering heart valve tissue from human pluripotent stem cells for improving understanding and treatment of valve disease. Her work has been recognised by multiple awards and distinctions including Australasian Society of Stem Cell Research Rising Star award (2024), Shirley E Freeman award for innovation from the Heart Foundation (2022), publication prizes from the International Society of Heart Research (2023), Stem Cells Australia (2017) and the Zhongmei Chen Young Award for Scientific Excellence from the International Society of Stem Cell Research (2024 and 2021).